1. |
杨凯璇, 周齐, 姜英玉, 等. 适应性设计随机对照临床试验. 中国卒中杂志, 2022, 17(10): 1152-1158.
|
2. |
Bhatt DL, Mehta C. Adaptive designs for clinical trials. N Engl J Med, 2016, 375(1): 65-74.
|
3. |
Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ, 2010, 340: c869.
|
4. |
Chamberlain JM, Kapur J, Shinnar S, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet, 2020, 395(10231): 1217-1224.
|
5. |
Guglielmetti L, Khan U, Velásquez GE, et al. Oral regimens for rifampin-resistant, fluoroquinolone-susceptible tuberculosis. N Engl J Med, 2025, 392(5): 468-482.
|
6. |
Proschan M, Evans S. Resist the temptation of response-adaptive randomization. Clin Infect Dis, 2020, 71(11): 3002-3004.
|
7. |
Hu F, Ye X, Zhang LX. Multi-arm covariate-adaptive randomization. Sci China Math, 2023, 66(1): 163-190.
|
8. |
Bugni FA, Canay IA, Shaikh AM. Inference under covariate-adaptive randomization. J Am Stat Assoc, 2018, 113(524): 1784-1796.
|
9. |
Jin H, Kim MO, Scheffler A, et al. Bayesian adaptive design for covariate-adaptive historical control information borrowing. Stat Med, 2023, 42(29): 5338-5352.
|
10. |
钱真真, 周莎, 于亚南, 等. 适应性随机化及其在临床试验中的应用操作要点. 中国循证医学杂志, 2022, 22(8): 971-977.
|
11. |
衡明莉, 王北琪, 王骏. 对美国FDA适应性设计指导原则的介绍. 中国临床药理学杂志, 2019, 35(12): 1316-1320.
|
12. |
Baldi Antognini A, Cecconi S, Frieri R, et al. Biomarker-driven optimal designs for patient enrollment restriction. Stat Methods Med Res, 2025, 2025: 9622802251327690.
|
13. |
Mei H, Xie J, Qin Y, et al. Network and covariate adjusted response-adaptive design for binary response. Stat Med, 2023, 42(29): 5369-5388.
|
14. |
王雨宁, 徐畅, 邹康, 等. 临床试验中适应性随机化的应用. 中国循证医学杂志, 2020, 20(5): 616-620.
|
15. |
Xiong W, Roy J, Liu H, et al. Leveraging machine learning: covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials. Contemp Clin Trials, 2024, 142: 107547.
|
16. |
Villar SS, Rosenberger WF. Covariate-adjusted response-adaptive randomization for multi-arm clinical trials using a modified forward looking Gittins index rule. Biometrics, 2018, 74(1): 49-57.
|
17. |
Qiao W, Ning J, Huang X. A clinical trial design with covariate-adjusted response-adaptive randomization using superiority confidence of treatments. Stat Biopharm Res, 2019, 11(4): 336-347.
|
18. |
Bandyopadhyay U, Bhattacharya R. An urn based covariate adjusted response adaptive allocation design. Stat Methods Med Res, 2012, 21(2): 135-148.
|
19. |
Selvaratnam S, Yi Y, Oyet A. Maximum likelihood estimation of generalized linear models for adaptive designs: Applications and asymptotics. Biom J, 2019, 61(3): 630-651.
|
20. |
Hu J, Zhu H, Hu F. A Unified Family of Covariate-Adjusted Response-Adaptive Designs Based on Efficiency and Ethics. J Am Stat Assoc, 2015, 110(509): 357-367.
|
21. |
Barbáchano Y, Coad DS. Inference following designs which adjust for imbalances in prognostic factors. Clin Trials, 2013, 10(4): 540-551.
|
22. |
韦红霞, 康佩, 刘颖欣, 等. 基于Adaptive Elastic Net与加速失效时间模型的亚组识别方法的应用拓展. 南方医科大学学报, 2021, 41(3): 391-398.
|
23. |
Guo Z, Liu Y, Xia L. Covariate selection for optimizing balance with an innovative adaptive randomization approach. Stat Methods Med Res, 2025, 2025: 9622802241313283.
|
24. |
高敬雅, 马维, 张绍洪, 等. 自适应临床试验设计的近期进展及展望. 数理统计与管理, 2020, 39(4): 595-610.
|
25. |
金秋百, 张颖, 姜枫, 等. 反应适应性随机的实施要点及其在中医药临床研究中的应用前景. 中医杂志, 2021, 62(17): 1478-1483.
|
26. |
Bandyopadhyay U, Bhattacharya R. A covariate-adjusted response-adaptive allocation in clinical trials for a general class of responses. Stat Med, 2013, 32(29): 5053-5061.
|